Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Neurology, Städtisches Klinikum Dresden, Dresden, Germany.
Lancet Public Health. 2022 Nov;7(11):e914-e922. doi: 10.1016/S2468-2667(22)00222-5.
Respiratory infection can be an immediate precursor to stroke and myocardial infarction. Influenza vaccination is associated with reduced risk of myocardial infarction and hospitalisation for cardiac disease, and influenza vaccination is strongly recommended for patients with heart disease. Evidence on whether the same protective association exists for stroke, and whether this potential effect is consistent across age and risk groups, is conflicting. We aimed to assess the risk of stroke after influenza vaccination in adults.
We obtained administrative data from the Alberta Health Care Insurance Plan (which covers all residents of Alberta, Canada) beginning on Sept 30, 2009, or May 15 of the year in which residents were recorded as being 18 years of age. Individuals were censored at the earliest of three events: death, recorded outmigration, or Dec 31, 2018. The outcome of interest was any stroke event, comprising acute ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and transient ischaemic attack. We used Andersen-Gill Cox models to analyse the hazard of any stroke event for individuals with recent (<182 days) influenza vaccination compared with those without recent influenza vaccination, with adjustment for age, sex, anticoagulant use, atrial fibrillation, chronic obstructive pulmonary disease, diabetes, hypertension, income quintile, and rural or urban home location. Two-way interaction terms between each individual covariate and vaccination status were used to assess for effect modification by risk factor. The association between vaccination and risk of each type of stroke was also modelled, adjusting for baseline covariates.
The study sample consisted of 4 141 209 adults (29 687 899 person-years of observation time) registered under the provincial health-care system between Sept 30, 2009, and Dec 31, 2018. 1 769 565 (42·73%) individuals received at least one vaccination during the study period, and 38 126 stroke events were recorded. Adjusted for demographics and comorbidities, recent influenza vaccination significantly reduced the hazard of stroke (hazard ratio 0·775 [95% CI 0·757-0·793]). This association persisted across all stroke types. We found effect modification by each covariate examined except for home location; however, vaccination was associated with a reduced risk of stroke overall across all ages and risk profiles with the exception of individuals without hypertension.
The risk of stroke is reduced among people who have recently been vaccinated against influenza compared with those who have not. This association extended to the entire adult population and was not limited to individuals with a baseline high risk of stroke. Further studies in a variety of settings are needed to evaluate whether influenza vaccination could be used as a public health strategy to prevent stroke.
None.
呼吸道感染可能是中风和心肌梗死的直接诱因。流感疫苗接种可降低心肌梗死和心脏病住院的风险,因此强烈建议心脏病患者接种流感疫苗。目前对于流感疫苗接种是否同样具有预防中风的效果,以及这种潜在效果是否在不同年龄组和风险人群中一致,证据相互矛盾。本研究旨在评估成年人接种流感疫苗后发生中风的风险。
我们从艾伯塔省医疗保险计划(覆盖加拿大艾伯塔省的所有居民)获得行政数据,数据起始日期为 2009 年 9 月 30 日或居民年满 18 岁当年的 5 月 15 日。个体在以下三种情况最早的一种时被删失:死亡、记录的迁出或 2018 年 12 月 31 日。主要结局为任何中风事件,包括急性缺血性中风、脑出血、蛛网膜下腔出血和短暂性脑缺血发作。我们使用 Andersen-Gill Cox 模型分析了近期(<182 天)接种流感疫苗的个体与未接种者相比发生任何中风事件的风险比,调整了年龄、性别、抗凝药物使用、心房颤动、慢性阻塞性肺疾病、糖尿病、高血压、收入五分位数和农村或城市家庭住址。使用每个个体协变量与接种状态之间的双向交互项来评估危险因素的修饰作用。还针对基线协变量调整了每种中风类型与接种的关联。
研究样本包括在省级医疗保健系统注册的 4141209 名成年人(29687899 人年观察时间),这些人在 2009 年 9 月 30 日至 2018 年 12 月 31 日期间接种了疫苗。1769565 人(42.73%)在研究期间至少接种了一次疫苗,38126 人发生了中风事件。调整了人口统计学和合并症因素后,近期流感疫苗接种显著降低了中风风险(风险比 0.775[95%CI 0.757-0.793])。这种关联在所有中风类型中均持续存在。我们发现除了家庭住址外,每个检查的协变量都存在修饰作用;然而,除了没有高血压的个体外,接种疫苗与降低中风风险相关,这种关联存在于所有年龄组和风险特征中。还需要在各种环境中进行进一步的研究,以评估流感疫苗接种是否可作为预防中风的公共卫生策略。
与未接种者相比,近期接种流感疫苗的人群发生中风的风险降低。这种关联扩展到了整个成年人群体,并且不限于基线中风风险较高的人群。